Concourse Financial Group Securities, Inc. Inventiva S.A. Transaction History
Concourse Financial Group Securities, Inc.
- $1.56 Billion
- Q2 2024
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding IVA
# of Institutions
8Shares Held
4.85MCall Options Held
0Put Options Held
0-
Yiheng Capital Management, L.P. San Francisco, CA2.64MShares$5.92 Million0.64% of portfolio
-
Nea Management Company, LLC Timonium, MD1.46MShares$3.28 Million0.41% of portfolio
-
Bvf Inc San Francisco, CA686KShares$1.54 Million0.06% of portfolio
-
Commonwealth Equity Services, LLC39.3KShares$88,0650.0% of portfolio
-
Ubs Group Ag10.6KShares$23,8530.0% of portfolio
About Inventiva S.A.
- Ticker IVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,134,200
- Market Cap $94.4M
- Description
- Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and other diseases. Its lead product candidate is Lanifibranor, which has completed Phase IIb clinical trial to treat NASH. The company als...